Targeted Leukodystrophy Diagnosis Based on Charges and Yields for Testing

Details

• Alternative Title:
  Am J Med Genet A
• Personal Author:
  Richards, Jackson ; Korgenski, E. Kent ; Taft, Ryan J. ; Vanderver, Adeline ; Bonkowsky, Joshua L.
• Description:
  Inherited leukodystrophies are a group of neurological disorders with significant morbidity and mortality. Children and their families can experience lengthy diagnostic odysseys; however, there is no data on the charges related to testing for diagnosis in leukodystrophy patients, compared to approaches using next-generation sequencing (NGS). Our objective was to determine charges related to the determination of diagnosis, and overall yield of diagnostic testing, for leukodystrophy patients. We determined and quantified all inpatient and outpatient lab testing, including brain MRIs, obtained for the purpose of diagnosis, in a retrospective population cohort of children with inherited leukodystrophies. Each patient had average charges of $8,231 (range $543-26,437) for diagnostic testing. Overall charges related to diagnosis for the entire cohort was $526,794. A final etiological diagnosis was determined in 34% of patients. In those in whom a specific diagnosis was determined, average time to diagnosis was 1.4 years. If NGS on the entire cohort had been performed instead, charges would have been ∼$359,600 (at $5,800/patient). Alternatively, a two-tier approach consisting of first, biochemical testing (serum very-long chain fatty acids and leukocyte lysosomal enzyme testing), and then with NGS for remaining undiagnosed patients, would have resulted in total cohort charges of $361,309. We have determined the charges directly associated with diagnostic testing in a population cohort of children with leukodystrophy. We conclude that appropriately incorporating NGS into diagnostic algorithms could lower charges; reduce time to diagnosis; and reduce amount of testing.
• Subjects:
  Article Charges Cohort Studies Demography Diagnostic Odyssey Diagnostic Tests, Routine Female Humans Leukodystrophy Leukodystrophy, Metachromatic Male Testing

  More +
• Source:
  Am J Med Genet A. 167A(11):2541-2543.
• Pubmed ID:
  26183797
• Pubmed Central ID:
  PMC4958453
• Document Type:
  Journal Article
• Funding:
  DP2 MH100008/MH/NIMH NIH HHS/United States ; DP2MH100008/DP/NCCDPHP CDC HHS/United States
• Issue:
  11
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:a75aea4c399fa93b662087726d7fd09a17344323037a4675a0b45a309b90c4f3
• Download URL:
  https://stacks.cdc.gov/view/cdc/40487/cdc_40487_DS1.pdf
• File Type:
  [PDF - 112.99 KB ]